SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-22-000009
Filing Date
2022-01-05
Accepted
2022-01-05 18:16:41
Documents
2
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164142458670226.html 4  
1 FORM 4 wf-form4_164142458670226.xml 4 3797
2 HECHT, BETH POA ex-24.htm EX-24 2972
  Complete submission text file 0001867096-22-000009.txt   8152
Mailing Address C/O NEOS THERAPEUTICS, INC. 2940 N. HIGHWAY 360 GRAND PRAIRIE TX 75050
Business Address
Hecht Beth (Reporting) CIK: 0001652410 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 22512833

Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations